Gerresheimer (GXI) Receives “Neutral” Rating from Deutsche Bank

Deutsche Bank reaffirmed their neutral rating on shares of Gerresheimer (ETR:GXI) in a research note issued to investors on Thursday.

Several other research analysts have also recently commented on the stock. Commerzbank set a €68.00 ($83.95) target price on shares of Gerresheimer and gave the stock a neutral rating in a research report on Wednesday, March 28th. HSBC set a €67.00 ($82.72) price target on shares of Gerresheimer and gave the stock a neutral rating in a research note on Monday, March 26th. JPMorgan Chase set a €74.00 ($91.36) price target on shares of Gerresheimer and gave the stock a neutral rating in a research note on Tuesday, March 20th. Kepler Capital Markets set a €65.00 ($80.25) price target on shares of Gerresheimer and gave the stock a sell rating in a research note on Friday, March 16th. Finally, Berenberg Bank set a €78.00 ($96.30) price target on shares of Gerresheimer and gave the stock a buy rating in a research note on Friday, March 9th. Two research analysts have rated the stock with a sell rating, eight have issued a hold rating and three have issued a buy rating to the company’s stock. The company presently has a consensus rating of Hold and an average price target of €68.67 ($84.77).

How to Become a New Pot Stock Millionaire

ETR GXI opened at €66.45 ($82.04) on Thursday. Gerresheimer has a 52 week low of €59.97 ($74.04) and a 52 week high of €78.25 ($96.60).

TRADEMARK VIOLATION WARNING: This piece of content was originally published by Ticker Report and is the sole property of of Ticker Report. If you are accessing this piece of content on another site, it was stolen and republished in violation of international copyright and trademark law. The correct version of this piece of content can be accessed at https://www.tickerreport.com/banking-finance/3342293/gerresheimer-gxi-receives-neutral-rating-from-deutsche-bank.html.

Gerresheimer Company Profile

Gerresheimer AG manufactures and sells specialty glass and plastic products primarily for the pharma and healthcare industry worldwide. It operates through two divisions, Plastics & Devices, and Primary Packaging Glass. The Plastics & Devices division offers drug delivery systems, including inhalers, pen systems, and injection systems; sterile and non-sterile prefillable syringe systems for the pharmaceutical and biotech industries; and disposables for various analysis systems that are used in laboratories and medical practices, quick tests for patients in medical practices or hospitals, skin-prick aids and lancets for diabetics, disposables and components for dialysis machines, and catheters and surgical devices.

Analyst Recommendations for Gerresheimer (ETR:GXI)

Receive News & Ratings for Gerresheimer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Gerresheimer and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Todd Michael Morgan Sells 12,600 Shares of Fiera Capital  Stock
Todd Michael Morgan Sells 12,600 Shares of Fiera Capital Stock
Travelport  Hits New 52-Week High and Low at $17.25
Travelport Hits New 52-Week High and Low at $17.25
Progressive  Sets New 1-Year High and Low Following Better-Than-Expected Earnings
Progressive Sets New 1-Year High and Low Following Better-Than-Expected Earnings
Harris  Rating Lowered to Sell at Zacks Investment Research
Harris Rating Lowered to Sell at Zacks Investment Research
Plantronics  Given Daily News Sentiment Rating of 0.19
Plantronics Given Daily News Sentiment Rating of 0.19
Genuine Parts  Earns Neutral Rating from Analysts at Guggenheim
Genuine Parts Earns Neutral Rating from Analysts at Guggenheim


Leave a Reply

© 2006-2018 Ticker Report. Google+.